|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
C.V. Starr Laboratory for Molecular Neuropharmacology, Department of Anesthesiology, Weill Cornell Medical College, New York, New York (F.J., M.Y., P.A.G., N.L.H.); and Departments of Anesthesiology and Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania (D.C., G.E.H.)
Volatile anesthetics are used clinically to produce analgesia, amnesia, unconsciousness, blunted autonomic responsiveness, and immobility. Previous work has shown that the volatile anesthetic isoflurane, at concentrations that produce unconsciousness (250–500 µM), enhances fast synaptic inhibition in the brain mediated by GABAA receptors (GABAA-Rs). In addition, isoflurane causes sedation at concentrations lower than those required to produce unconsciousness or analgesia. In this study, we found that isoflurane, at low concentrations (25–85 µM) associated with its sedative actions, elicits a sustained current associated with a conductance increase in thalamocortical neurons in the mouse ventrobasal (VB) nucleus. These isoflurane-evoked currents reversed polarity close to the Cl– equilibrium potential and were totally blocked by the GABAA-R antagonist gabazine. Isoflurane (25–250 µM) produced no sustained current in VB neurons from GABAA-R
4-subunit knockout (Gabra4–/–) mice, although 250 µM isoflurane enhanced synaptic inhibition in VB neurons from both wild-type and Gabra4–/– mice. These data indicate an obligatory requirement for
4-subunit expression in the generation of the isoflurane-activated current. In addition, isoflurane directly activated
4β2
GABAA-Rs expressed in human embryonic kidney 293 cells, and it was more potent at
4β2
than at
1β2
2 receptors (the presumptive extrasynaptic and synaptic GABAA-R subtypes in VB neurons). We conclude that the extrasynaptic GABAA-Rs of thalamocortical neurons are sensitive to low concentrations of isoflurane. In view of the crucial role of the thalamus in sensory processing, sleep, and cognition, the modulation of these extrasynaptic GABAA-Rs by isoflurane may contribute to the sedation and hypnosis associated with low doses of this anesthetic agent.
Address correspondence to: Dr. Neil Harrison, Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, Room A-1050, New York, NY 10065. E-mail: neh2001{at}med.cornell.edu
This article has been cited by other articles:
![]() |
D. Belelli, N. L. Harrison, J. Maguire, R. L. Macdonald, M. C. Walker, and D. W. Cope Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function J. Neurosci., October 14, 2009; 29(41): 12757 - 12763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Bieda, H. Su, and M. B. MacIver Anesthetics Discriminate Between Tonic and Phasic {gamma}-Aminobutyric Acid Receptors on Hippocampal CA1 Neurons Anesth. Analg., February 1, 2009; 108(2): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jia, D. Chandra, G. E. Homanics, and N. L. Harrison Ethanol Modulates Synaptic and Extrasynaptic GABAA Receptors in the Thalamus J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 475 - 482. [Abstract] [Full Text] [PDF] |
||||